Insulin Delivery Device Market

Table of Content

Chapter 1. Preface

    1.1. Report Description

    1.2. Report Methodology

    1.3. Assumptions

Chapter 2. Market Synopsis

Chapter 3. Porter’s Five Forces Analysis

    3.1. Bargaining Power of Suppliers

    3.2. Bargaining Power of Buyers

    3.3. Threat of New Entrants

    3.4. Threat of Substitutes

    3.5. Intensity of Rivalry

Chapter 4. Industry Overview

    4.1. Market Definition

    4.2. Market Drivers

        4.2.1. Increasing prevalence of diabetes enhance the market growth

        4.2.2. Globally rising obesity is increasing the prevalence of diabetes

        4.2.3. Advanced features of insulin delivery devices attract end users

        4.2.4. Rising awareness among people about diabetes care

    4.3. Impact Analysis of Market Drivers

    4.4. Market Restraints

        4.4.1. Risk and complications associated with delivery of insulin

        4.4.2. High cost of insulin analog impedes the market growth

    4.5. Impact Analysis of Market Restraints

    4.6. Market Trends

        4.6.1. Artificial pancreas is gaining popularity in the insulin delivery devices market

        4.6.2. Home infusion therapy is gaining importance in treatment of diabetes

Chapter 5. Global Market Size and Forecast

Chapter 6. Market Size and Forecast by Device

    6.1. Insulin Syringes

    6.2. Insulin Pens

    6.3. Insulin Pumps

    6.4. Insulin Jet Injectors

Chapter 7. Market Size and Forecast by Geography

    7.1. North America

        7.1.1. Scenario in the U.S.

        7.1.2. Scenario in Canada

    7.2. Europe

        7.2.1. Scenario in Germany

        7.2.2. Scenario in France

        7.2.3. Scenario in the U.K.

        7.2.4. Scenario in Italy

        7.2.5. Scenario in Spain

    7.3. Asia

        7.3.1. Scenario in Japan

        7.3.2. Scenario in China

        7.3.3. Scenario in India

    7.4. Latin America

        7.4.1. Scenario in Brazil

Chapter 8. Competitive Scenario

    8.1. Market Share Analysis

    8.2. Competitive Benchmarking

Chapter 9. Company Profiles

    9.1. Abbott Laboratories

        9.1.1. Company Overview

        9.1.2. Products and Services

        9.1.3. Financial Performance

        9.1.4. Recent Developments

    9.2. Novo Nordisk A/S

        9.2.1. Company Overview

        9.2.2. Products and Services

        9.2.3. Financial Performance

        9.2.4. Recent Developments

    9.3. Eli Lilly and Company

        9.3.1. Company Overview

        9.3.2. Products and Services

        9.3.3. Financial Performance

        9.3.4. Recent Developments

    9.4. Medtronic, Inc.

        9.4.1. Company Overview

        9.4.2. Products and Services

        9.4.3. Financial Performance

        9.4.4. Recent Developments

    9.5. Sanofi

        9.5.1. Company Overview

        9.5.2. Products and Services

        9.5.3. Financial Performance

        9.5.4. Recent Developments

    9.6. Becton, Dickinson and Company

        9.6.1. Company Overview

        9.6.2. Products and Services

        9.6.3. Financial Performance

        9.6.4. Recent Developments

    9.7. F. Hoffmann-La Roche, Ltd.

        9.7.1. Company Overview

        9.7.2. Products and Services

        9.7.3. Financial Performance

        9.7.4. Recent Developments

    9.8. Insulet Corporation

        9.8.1. Company Overview

        9.8.2. Products and Services

        9.8.3. Financial Performance

        9.8.4. Recent Developments

    9.9. Ypsomed Holding AG

        9.9.1. Company Overview

        9.9.2. Products and Services

        9.9.3. Financial Performance

        9.9.4. Recent Developments

    9.10. Animas Corporation

        9.10.1. Company Overview

        9.10.2. Products and Services

        9.10.3. Financial Performance

        9.10.4. Recent Developments

    9.11. B. Braun Melsungen AG

        9.11.1. Company Overview

        9.11.2. Products and Services

        9.11.3. Financial Performance

        9.11.4. Recent Developments

List Of Table

TABLE 1: Market Snapshot: Global market for insulin delivery devices (2014 and 2020)

TABLE 2: Drivers of insulin delivery devices market: Impact analysis

TABLE 3: Restraints for insulin delivery devices market: Impact analysis

TABLE 4: Global market for insulin delivery devices, by geography, 2010 - 2013 (USD million)

TABLE 5: Global market for insulin delivery devices, by geography, 2014 - 2020 (USD million)

TABLE 6: Global market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 7: Global market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 8: Global market for insulin syringes, by geography, 2010 - 2013 (USD million)

TABLE 9: Global market for insulin syringes, by geography, 2014 - 2020 (USD million)

TABLE 10: Global market for insulin pen, by geography, 2010 - 2013 (USD million)

TABLE 11: Global market for insulin pen, by geography, 2014 - 2020 (USD million)

TABLE 12: Global market for insulin pumps, by geography, 2010 - 2013 (USD million)

TABLE 13: Global market for insulin pumps, by geography, 2014 - 2020 (USD million)

TABLE 14: Global market for insulin jet injectors, by geography, 2010 - 2013 (USD million)

TABLE 15: Global market for insulin jet injectors, by geography, 2014 - 2020 (USD million)

TABLE 16: The North American market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 17: The North American market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 18: The North American market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 19: The North American market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 20: The U.S. market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 21: The U.S. market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 22: Canadian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 23: Canadian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 24: The European market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 25: The European market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 26: The European market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 27: The European market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 28: German market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 29: German market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 30: French market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 31: French market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 32: The U.K. market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 33: The U.K. market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 34: Italian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 35: Italian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 36: Spanish market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 37: Spanish market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 38: The Asian market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 39: The Asian market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 40: The Asian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 41: The Asian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 42: Japanese market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 43: Japanese market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 44: Chinese market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 45: Chinese market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 46: Indian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 47: Indian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 48: The Latin American market for insulin delivery devices, by country, 2010 - 2013 (USD million)

TABLE 49: The Latin American market for insulin delivery devices, by country, 2014 - 2020 (USD million)

TABLE 50: The Latin American market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 51: The Latin American market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 52: Brazilian market for insulin delivery devices, by device, 2010 - 2013 (USD million)

TABLE 53: Brazilian market for insulin delivery devices, by device, 2014 - 2020 (USD million)

TABLE 54: Abbott’s major product categories

TABLE 55: Novo Nordisk’s product segments

TABLE 56: Lilly’s product segments

TABLE 57: Medtronic’s product segments

TABLE 58: Sanofi’s major product categories

TABLE 59: BD’s product segments

TABLE 60: Roche’s product categories

TABLE 61: Insulet’s product category

TABLE 62: Ypsomed’s product categories

TABLE 63: Animas’s major product categories

TABLE 64: B. Braun product divisions

- List Of Chart -

FIG. 1: Insulin delivery devices market: Porter\'s five forces analysis

FIG. 2: Major insulin delivery devices

FIG. 3: Emerging insulin delivery technologies

FIG. 4: Number of people with diabetes mellitus (20 - 79 years) in major countries, 2010 and 2030 (million)

FIG. 5: Prevalence of overweight and obese males aged 30 and above, 2005 and 2015 (%)

FIG. 6: Prevalence of overweight and obese females aged 30 and above, 2005 and 2015 (%)

FIG. 7: Global insulin delivery devices market share, by region, by value, 2013

FIG. 8: Global insulin delivery devices market share, by device, by value, 2013

FIG. 9: Global insulin syringes market share, by region, by value, 2013

FIG. 10: Global insulin pens market share, by region, by value, 2013

FIG. 11: Global insulin pumps market share, by region, by value, 2013

FIG. 12: Global insulin jet injectors market share, by region, by value, 2013

FIG. 13: The North American insulin delivery devices market share, by country, by value, 2013

FIG. 14: The North American insulin delivery devices market share, by device, by value, 2013

FIG. 15: The U.S. insulin delivery devices market share, by device, by value, 2013

FIG. 16: Prevalence of diabetes mellitus in people aged 20 - 79, 2010 and 2030 (thousand)

FIG. 17: Canadian insulin delivery devices market share, by device, by value, 2013

FIG. 18: The European insulin delivery devices market share, by country, by value, 2013

FIG. 19: The European insulin delivery devices market share, by device, by value, 2013

FIG. 20: German insulin delivery devices market share, by device, by value, 2013

FIG. 21: French insulin delivery devices market share, by device, by value, 2013

FIG. 22: The U.K. insulin delivery devices market share, by device, by value, 2013

FIG. 23: Italian insulin delivery devices market share, by device, by value, 2013

FIG. 24: Spanish insulin delivery devices market share, by device, by value, 2013

FIG. 25: The Asian insulin delivery devices market share, by country, by value, 2013

FIG. 26: The Asian insulin delivery devices market share, by device, by value, 2013

FIG. 27: Japanese insulin delivery devices market share, by device, by value, 2013

FIG. 28: Chinese insulin delivery devices market share, by device, by value, 2013

FIG. 29: Indian insulin delivery devices market share, by device, by value, 2013

FIG. 30: The Latin American insulin delivery devices market share, by country, by value, 2013

FIG. 31: The Latin American insulin delivery devices market share, by device, by value, 2013

FIG. 32: Brazilian insulin delivery devices market share, by device, by value, 2013

FIG. 33: Market share analysis of insulin delivery devices market, by value, 2013

FIG. 34: Competitive landscape of insulin delivery devices market

FIG. 35: Abbott net sales and net earnings, 2011 - 2013 (USD million)

FIG. 36: Novo Nordisk net sales and net profit, 2011 - 2013 (USD million)

FIG. 37: Lilly revenue and net income, 2011 - 2013 (USD million) 

FIG. 38: Medtronic net sales and net earnings, 2011 - 2013 (USD million)

FIG. 39: Sanofi net sales and net profit, 2011 - 2013 (USD million)

FIG. 40: BD revenue and net income, 2011 - 2013 (USD Million)

FIG. 41: Roche Group sales and net income, 2011 - 2013 (USD Million)

FIG. 42: Insulet revenue and net income, 2011 - 2013 (USD Million)

FIG. 43: Ypsomed sales and net profit, 2011 - 2013 (USD Million)

FIG. 44: B. Braun sales and consolidated net profit, 2011 - 2013 (USD Million)